Curbstone Financial Management Corp Exact Sciences Corp Transaction History

Curbstone Financial Management Corp

  • $458 Million
  • Q3 2024

A detailed history of Curbstone Financial Management Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Curbstone Financial Management Corp holds 7,850 shares of EXAS stock, worth $451,218. This represents 0.12% of its overall portfolio holdings.

Number of Shares
7,850
Previous 15,830 50.41%
Holding current value
$451,218
Previous $668,000 20.06%
% of portfolio
0.12%
Previous 0.15%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
SELL
$42.43 - $70.83 $338,591 - $565,223
-7,980 Reduced 50.41%
7,850 $534,000
Q2 2024

Jul 03, 2024
BUY
$41.33 - $74.26 $8,266 - $14,852
200 Added 1.28%
15,830 $668,000
Q1 2024

Apr 09, 2024
SELL
$56.27 - $73.77 $36,575 - $47,950
-650 Reduced 3.99%
15,630 $1.08 Million
Q4 2023

Jan 08, 2024
BUY
$59.06 - $75.72 $53,154 - $68,148
900 Added 5.85%
16,280 $1.2 Million
Q2 2023

Jul 05, 2023
BUY
$62.68 - $95.05 $12,536 - $19,010
200 Added 1.32%
15,380 $1.44 Million
Q1 2023

May 12, 2023
BUY
$47.19 - $70.77 $58,987 - $88,462
1,250 Added 8.97%
15,180 $1.03 Million
Q4 2022

Jan 19, 2023
SELL
$30.35 - $53.15 $126,863 - $222,167
-4,180 Reduced 23.08%
13,930 $690,000
Q3 2022

Oct 05, 2022
SELL
$31.97 - $49.37 $78,326 - $120,956
-2,450 Reduced 11.92%
18,110 $588,000
Q2 2022

Aug 04, 2022
SELL
$35.61 - $76.23 $131,757 - $282,051
-3,700 Reduced 15.25%
20,560 $810,000
Q1 2022

Apr 18, 2022
BUY
$57.56 - $82.54 $22,448 - $32,190
390 Added 1.63%
24,260 $1.7 Million
Q3 2021

Oct 06, 2021
BUY
$90.24 - $124.05 $58,656 - $80,632
650 Added 2.8%
23,870 $2.28 Million
Q2 2021

Jul 09, 2021
BUY
$93.66 - $139.27 $115,201 - $171,302
1,230 Added 5.59%
23,220 $2.89 Million
Q1 2021

Apr 05, 2021
BUY
$116.57 - $155.01 $94,421 - $125,558
810 Added 3.82%
21,990 $2.9 Million
Q4 2020

Jan 14, 2021
SELL
$99.61 - $142.12 $24,902 - $35,530
-250 Reduced 1.17%
21,180 $2.81 Million
Q3 2020

Oct 02, 2020
BUY
$72.92 - $102.01 $20,417 - $28,562
280 Added 1.32%
21,430 $2.19 Million
Q2 2020

Jul 10, 2020
BUY
$55.75 - $92.75 $8,362 - $13,912
150 Added 0.71%
21,150 $1.84 Million
Q1 2020

Apr 20, 2020
SELL
$37.9 - $104.44 $17,813 - $49,086
-470 Reduced 2.19%
21,000 $1.22 Million
Q4 2019

Jan 10, 2020
BUY
$77.66 - $99.74 $1.67 Million - $2.14 Million
21,470 New
21,470 $1.99 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Curbstone Financial Management Corp Portfolio

Follow Curbstone Financial Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email